rs113845886

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014780.5(CUL7):​c.1027C>T​(p.Pro343Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,614,180 control chromosomes in the GnomAD database, including 81 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P343P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.013 ( 44 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 37 hom. )

Consequence

CUL7
NM_014780.5 missense

Scores

7
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.48

Publications

2 publications found
Variant links:
Genes affected
CUL7 (HGNC:21024): (cullin 7) The protein encoded by this gene is a component of an E3 ubiquitin-protein ligase complex. The encoded protein interacts with TP53, CUL9, and FBXW8 proteins. Defects in this gene are a cause of 3M syndrome type 1 (3M1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
KLC4 (HGNC:21624): (kinesin light chain 4) Predicted to be located in cytoplasm and microtubule. Predicted to be part of kinesin complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002896458).
BP6
Variant 6-43051174-G-A is Benign according to our data. Variant chr6-43051174-G-A is described in ClinVar as Benign. ClinVar VariationId is 356852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0126 (1917/152292) while in subpopulation AFR AF = 0.0431 (1791/41550). AF 95% confidence interval is 0.0414. There are 44 homozygotes in GnomAd4. There are 931 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 44 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CUL7NM_014780.5 linkc.1027C>T p.Pro343Ser missense_variant Exon 4 of 26 ENST00000265348.9 NP_055595.2 Q14999-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CUL7ENST00000265348.9 linkc.1027C>T p.Pro343Ser missense_variant Exon 4 of 26 1 NM_014780.5 ENSP00000265348.4 Q14999-1
ENSG00000288564ENST00000673761.1 linkn.*1061C>T non_coding_transcript_exon_variant Exon 9 of 9 ENSP00000501018.1 A0A669KAX9
ENSG00000288564ENST00000673761.1 linkn.*1061C>T 3_prime_UTR_variant Exon 9 of 9 ENSP00000501018.1 A0A669KAX9

Frequencies

GnomAD3 genomes
AF:
0.0126
AC:
1910
AN:
152174
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0431
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00635
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00321
AC:
807
AN:
251348
AF XY:
0.00256
show subpopulations
Gnomad AFR exome
AF:
0.0429
Gnomad AMR exome
AF:
0.00231
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000968
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00121
AC:
1774
AN:
1461888
Hom.:
37
Cov.:
34
AF XY:
0.00109
AC XY:
792
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0412
AC:
1379
AN:
33480
American (AMR)
AF:
0.00259
AC:
116
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000270
AC:
30
AN:
1112010
Other (OTH)
AF:
0.00331
AC:
200
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
118
235
353
470
588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0126
AC:
1917
AN:
152292
Hom.:
44
Cov.:
32
AF XY:
0.0125
AC XY:
931
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0431
AC:
1791
AN:
41550
American (AMR)
AF:
0.00634
AC:
97
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68026
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
98
195
293
390
488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00434
Hom.:
8
Bravo
AF:
0.0143
ESP6500AA
AF:
0.0397
AC:
175
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00392
AC:
476
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 23, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

3M syndrome 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D;.
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.70
T;T
MetaRNN
Benign
0.0029
T;T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
3.5
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-2.9
D;D
REVEL
Benign
0.21
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.029
D;D
Polyphen
0.99
D;.
Vest4
0.16
MVP
0.84
MPC
0.22
ClinPred
0.044
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.14
gMVP
0.25
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113845886; hg19: chr6-43018912; API